Tags

Type your tag names separated by a space and hit enter

Paediatric pneumococcal disease in Central Europe.
Eur J Clin Microbiol Infect Dis. 2011 Nov; 30(11):1311-20.EJ

Abstract

Streptococcus pneumoniae causes considerable global paediatric morbidity and mortality, despite the availability of safe and effective pneumococcal conjugate vaccines (PCVs). To justify the introduction of PCVs, accurate information on the burden of disease is required. Here, we present an appraisal of the pneumococcal epidemiological situation in 11 Central European countries. The data are based on study findings presented at the 12th Central European Vaccine Advisory Group (CEVAG) meeting, held on 21-22 May 2010 in Sofia, Bulgaria, and a literature review of the PubMed database using the search terms 'pneumococcal' or 'Streptococcus pneumoniae', in combination with 'otitis media', 'pneumonia', 'meningitis' or 'bacteraemia/sepsis', and '[Central European country name]'. The incidence of pneumococcal disease appears to be lower in Central Europe than previously reported for Europe as a whole, with the highest risk in infants aged 0-2 years. The fatality rates in the under fives from invasive infections are up to 40%. A paucity of comprehensive country-specific data on pneumococcal disease burden arises from the lack of homogenous surveillance programmes. Standardised, active surveillance systems are required for the accurate evaluation of the pneumococcal disease burden in the region. Only then can the need for vaccination be addressed.

Authors+Show Affiliations

Faculty of Military Health Sciences, University of Defence, Hradec Kralove, Czech Republic. prymula@fnhk.czNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't
Review

Language

eng

PubMed ID

21667219

Citation

Prymula, R, et al. "Paediatric Pneumococcal Disease in Central Europe." European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology, vol. 30, no. 11, 2011, pp. 1311-20.
Prymula R, Chlibek R, Ivaskeviciene I, et al. Paediatric pneumococcal disease in Central Europe. Eur J Clin Microbiol Infect Dis. 2011;30(11):1311-20.
Prymula, R., Chlibek, R., Ivaskeviciene, I., Mangarov, A., Mészner, Z., Perenovska, P., Richter, D., Salman, N., Simurka, P., Tamm, E., Tešović, G., Urbancikova, I., & Usonis, V. (2011). Paediatric pneumococcal disease in Central Europe. European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology, 30(11), 1311-20. https://doi.org/10.1007/s10096-011-1241-y
Prymula R, et al. Paediatric Pneumococcal Disease in Central Europe. Eur J Clin Microbiol Infect Dis. 2011;30(11):1311-20. PubMed PMID: 21667219.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Paediatric pneumococcal disease in Central Europe. AU - Prymula,R, AU - Chlibek,R, AU - Ivaskeviciene,I, AU - Mangarov,A, AU - Mészner,Zs, AU - Perenovska,P, AU - Richter,D, AU - Salman,N, AU - Simurka,P, AU - Tamm,E, AU - Tešović,G, AU - Urbancikova,I, AU - Usonis,V, Y1 - 2011/06/11/ PY - 2010/12/27/received PY - 2011/03/21/accepted PY - 2011/6/14/entrez PY - 2011/6/15/pubmed PY - 2014/3/8/medline SP - 1311 EP - 20 JF - European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology JO - Eur J Clin Microbiol Infect Dis VL - 30 IS - 11 N2 - Streptococcus pneumoniae causes considerable global paediatric morbidity and mortality, despite the availability of safe and effective pneumococcal conjugate vaccines (PCVs). To justify the introduction of PCVs, accurate information on the burden of disease is required. Here, we present an appraisal of the pneumococcal epidemiological situation in 11 Central European countries. The data are based on study findings presented at the 12th Central European Vaccine Advisory Group (CEVAG) meeting, held on 21-22 May 2010 in Sofia, Bulgaria, and a literature review of the PubMed database using the search terms 'pneumococcal' or 'Streptococcus pneumoniae', in combination with 'otitis media', 'pneumonia', 'meningitis' or 'bacteraemia/sepsis', and '[Central European country name]'. The incidence of pneumococcal disease appears to be lower in Central Europe than previously reported for Europe as a whole, with the highest risk in infants aged 0-2 years. The fatality rates in the under fives from invasive infections are up to 40%. A paucity of comprehensive country-specific data on pneumococcal disease burden arises from the lack of homogenous surveillance programmes. Standardised, active surveillance systems are required for the accurate evaluation of the pneumococcal disease burden in the region. Only then can the need for vaccination be addressed. SN - 1435-4373 UR - https://www.unboundmedicine.com/medline/citation/21667219/Paediatric_pneumococcal_disease_in_Central_Europe_ L2 - https://dx.doi.org/10.1007/s10096-011-1241-y DB - PRIME DP - Unbound Medicine ER -